分期结膜瓣联合角膜移植治疗药物治疗无效的感染性角膜炎的结局
这项回顾性单中心研究纳入29眼严重感染性角膜炎,均对药物治疗无反应且基质溃疡深度≥50%角膜厚度,先接受Gundersen结膜瓣手术,至少4个月后行角膜移植。结膜瓣术后感染全部愈合;末次随访时,穿透性角膜移植、深板层角膜移植和蘑菇状角膜移植后最佳矫正视力≥20/200的比例分别为50%、33.3%和70%,移植失败率分别为75%、100%和20%。作者认为分期结膜瓣联合角膜移植是避免高危“热眼”角膜移植的替代治疗选择。
要点
- 29眼严重感染性角膜炎经结膜瓣手术后感染均愈合,平均16.3±16.1个月后行角膜移植。
- 末次随访最佳矫正视力≥20/200者:穿透性角膜移植50%、深板层角膜移植33.3%、蘑菇状角膜移植70%。
- 移植失败率:穿透性角膜移植75%、深板层角膜移植100%、蘑菇状角膜移植20%。
核心结论
- 作者认为,结膜瓣手术后分期行角膜移植是严重感染性角膜炎避免高危“热眼”角膜移植的一种替代治疗选择。
研究设计与样本
- 回顾性单中心研究,纳入29例患者的29眼感染性角膜炎,均对药物治疗无反应且基质溃疡深度≥50%角膜厚度。
- 所有眼均先行Gundersen结膜瓣手术,至少4个月后行穿透性角膜移植、深板层角膜移植或蘑菇状角膜移植。
- 结局指标包括最佳矫正视力、内皮细胞计数、移植存活率和并发症。
主要发现
- 结膜瓣手术后所有眼感染均愈合;结膜瓣与角膜移植之间的平均时间间隔为16.3±16.1个月。
- 55%的患者接受穿透性角膜移植,35%接受蘑菇状角膜移植,10%接受深板层角膜移植;平均随访39.6±34.3个月。
- 末次随访时,最佳矫正视力≥20/200的比例在穿透性角膜移植后为50%、深板层角膜移植后为33.3%、蘑菇状角膜移植后为70%。
- 穿透性角膜移植后平均年内皮细胞丢失为24.5%,蘑菇状角膜移植后为10.7%。
- 移植失败率在穿透性角膜移植后为75%、深板层角膜移植后为100%、蘑菇状角膜移植后为20%。
关键数值与推荐
- 最常见并发症为无免疫排斥的内皮失代偿(34.5%,发生于31.1±25.1个月后)和移植排斥(17.2%,发生于10.2±7.9个月后,均见于穿透性角膜移植组)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To explore the outcomes of conjunctival flap (CF) followed by keratoplasty in patients with severe infectious keratitis (IK) unresponsive to medical treatment. METHODS: This is a retrospective monocentric study including 29 eyes of 29 patients with IK resistant to antibiotic treatment associated with stromal ulcer deepening to ≥50% of corneal thickness. All eyes underwent Gundersen's CF procedure and penetrating keratoplasty (PK), deep anterior lamellar keratoplasty (DALK) or mushroom keratoplasty (MK), at least 4 months thereafter. Outcome measures included corrected distance visual acuity (CDVA), endothelial cell count (ECC), graft survival and complications. RESULTS: IK healed in all eyes following CF. The mean time interval between CF and keratoplasty was 16.3±16.1 months. 55% of patients underwent PK, 35% MK and 10% DALK. Mean follow-up duration was 39.6±34.3 months. At the last available follow-up, a CDVA≥20/200 was obtained in 50%, 33.3% and 70% of cases, respectively after PK, DALK and MK. Mean annual endothelial cell loss was 24.5% following PK and 10.7% following MK. Overall, graft failure occurred in 75% of cases after PK, 100% after DALK and 20% after MK. The most frequent complications were endothelial decompensation without immunological rejection (34.5%, after 31.1±25.1 months) and graft rejection (17.2%, after 10.2±7.9 months, all in the PK group). CONCLUSION: CF surgery followed by staged keratoplasty represents an alternative therapeutic approach to avoid high-risk keratoplasty 'a chaud' in cases of severe IK.
引用
- Kilian R, Pellegrini M, Yu AC, et al. Outcomes of staged conjunctival flap and corneal transplantation for infectious keratitis resistant to medical treatment. Br J Ophthalmol. 2025. PMID: 39643279. doi:10.1136/bjo-2024-326225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。